MiMedx Group (MDXG) Financials: Revenue & Earnings

MDXG price $3.95 +0.05 +1.31%

Ticker
MDXG
Price
$3.95
Change
+0.05 +1.31%
Market cap ?
$575.93M
Beta ?
1.42
Sector
Healthcare
Industry
Biotechnology

Fair value

MDXG fair value $4.04. Price $3.95. Price is about fair value.

Above fair value, but less expensive than usual. A smaller premium than on 66% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Average free cash flow, last three years 54.09M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.4). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 145.76M. Net debt -143.59M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare MDXG

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-28—0.00—68.56M
2026-07-29-0.05-0.0564.36M63.46M
2026-04-29-0.05-0.0758.99M65.80M
2026-02-250.140.09118.09M106.78M
2025-10-290.150.07113.72M101.91M
2025-07-300.100.0698.61M90.61M
2025-04-300.060.0688.20M86.32M
2025-02-260.070.0792.91M89.42M
2024-10-300.050.0484.06M82.64M
2024-07-310.080.0887.21M89.01M
2024-04-300.070.0584.71M79.32M
2024-02-280.320.0886.83M85.12M
2023-10-300.060.0581.71M76.87M
2023-08-01-0.00-0.0281.26M74.84M
2023-05-02-0.06-0.0971.68M64.32M
2023-02-28-0.02-0.0474.38M74.54M
2022-11-02-0.09-0.0867.69M66.73M
2022-08-02-0.11-0.0666.88M65.07M
2022-05-03-0.11-0.1058.89M54.10M
2022-02-280.01-0.0367.41M63.69M
2021-11-02-0.04-0.0863.07M60.26M
2021-08-03-0.03-0.0768.17M58.77M
2021-04-28-0.09-0.1959.97M82.38M
2021-03-08-0.17-0.0568.55M62.00M
2020-11-04-0.480.1964.30M121.97M
2020-08-04-0.080.1553.65M117.89M
2020-07-06-0.040.1461.74M105.92M
2020-03-170.380.0976.40M22.12M
2018-09-30-0.00—86.96M—
2018-06-300.02—95.42M—
2018-03-310.04—84.15M—
2017-12-310.31—87.55M—
2017-10-260.080.0884.57M84.57M
2017-07-260.070.0776.41M76.41M
2017-04-280.070.0772.61M72.61M
2017-02-230.070.0869.88M53.23M
2016-10-270.060.0664.43M64.43M
2016-07-260.050.0757.34M80.28M
2016-04-250.040.0553.37M66.71M
2016-02-230.110.0651.84M48.11M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-02DOUG RICESell12.75K$3.9550.36K
2026-06-24Maersk-Moller KimberlySell19.82K$3.8375.91K
2026-06-10BIERMAN JAMES LBuy50.91K$3.64185.32K
2026-06-10PUHY DOROTHY EBuy50.91K$3.64185.32K
2026-06-10Newton ToddBuy50.91K$3.64185.32K
2026-06-10HAWKINS WILLIAM ABuy50.91K$3.64185.32K
2026-06-10Olson TiffanyBuy50.91K$3.64185.32K
2026-03-13Hulse William Frank IVSell20.25K$4.3888.67K
2026-03-13Maersk-Moller KimberlySell6.76K$4.3829.62K
2026-03-10Maersk-Moller KimberlyBuy42.84K$4.50192.80K
2026-03-10Maersk-Moller KimberlySell21.27K$4.5095.72K
2026-03-10Hulse William Frank IVBuy136.36K$4.50613.64K
2026-03-10Hulse William Frank IVSell61.46K$4.50276.57K
2026-03-10DOUG RICEBuy243.00K$4.501.09M
2026-03-10DOUG RICESell96.36K$4.50433.63K
2026-03-04Capper Joseph HBuy310.57K$5.101.58M
2026-03-04Capper Joseph HBuy371.09K——
2026-03-04DOUG RICEBuy74.16K——
2026-03-04DOUG RICEBuy62.07K$5.10316.55K
2026-03-04Hulse William Frank IVBuy74.99K——
2026-03-04Hulse William Frank IVBuy62.76K$5.10320.07K
2026-03-04Whitlow Ricci SBuy74.16K——
2026-03-04Whitlow Ricci SBuy62.07K$5.10316.55K
2026-03-04Maersk-Moller KimberlyBuy74.16K——
2026-03-04Maersk-Moller KimberlyBuy62.07K$5.10316.55K
2026-02-13Whitlow Ricci SSell61.96K$5.12317.24K
2025-11-06Maersk-Moller KimberlySell58.30K$7.42432.33K
2025-07-03DOUG RICESell12.75K$6.3480.83K
2025-06-24Maersk-Moller KimberlySell12.03K$5.9671.72K
2025-06-18BEHRENS M KATHLEENBuy28.61K$6.47185.10K
2025-06-18BIERMAN JAMES LBuy28.61K$6.47185.10K
2025-06-18HAWKINS WILLIAM ABuy28.61K$6.47185.10K
2025-06-18LAURENCIN CATO TBuy28.61K$6.47185.10K
2025-06-18Olson TiffanyBuy28.61K$6.47185.10K
2025-06-18PUHY DOROTHY EBuy28.61K$6.47185.10K
2025-05-08Hulse William Frank IVSell8.88K$7.4265.87K
2025-05-02Capper Joseph HBuy200.00K$6.341.27M
2025-04-23Hulse William Frank IVSell8.88K$6.7660.00K
2025-04-08Hulse William Frank IVSell8.88K$6.8660.89K
2025-04-01Maersk-Moller KimberlySell1.76K$7.5013.21K
2025-03-17Maersk-Moller KimberlySell1.76K$8.0414.14K
2025-03-13Hulse William Frank IVSell34.23K$7.89270.07K
2025-03-13Hulse William Frank IVSell20.37K$7.89160.69K
2025-03-13Maersk-Moller KimberlySell4.11K$7.8932.40K
2025-03-10Hulse William Frank IVSell81.45K$7.80635.28K
2025-03-03Maersk-Moller KimberlyBuy45.93K——
2025-03-03Maersk-Moller KimberlyBuy36.49K$8.30302.83K
2025-03-03Whitlow Ricci SBuy45.93K——
2025-03-03Whitlow Ricci SBuy36.49K$8.30302.83K
2025-03-03Hulse William Frank IVBuy46.44K——
2025-03-03Hulse William Frank IVBuy76.51K——
2025-03-03Hulse William Frank IVBuy36.89K$8.03296.23K
2025-03-03DOUG RICEBuy36.49K$8.30302.83K
2025-03-03DOUG RICEBuy45.93K——
2025-03-03Capper Joseph HBuy177.36K$8.301.47M
2025-03-03Capper Joseph HBuy223.27K——
2025-02-28Maersk-Moller KimberlySell2.11K$8.4017.74K
2025-02-13Whitlow Ricci SSell61.42K$8.28508.56K
2024-12-11Maersk-Moller KimberlyBuy125.58K——
2024-07-08DOUG RICESell12.75K$6.7986.57K
2024-06-24Maersk-Moller KimberlySell0——
2024-06-24Maersk-Moller KimberlySell0——
2024-06-24Maersk-Moller KimberlySell0——
2024-06-24Maersk-Moller KimberlySell0——
2024-06-24Maersk-Moller KimberlySell39.31K$8.63339.23K
2024-06-05LAURENCIN CATO TBuy23.19K$7.26168.36K
2024-06-05BIERMAN JAMES LBuy23.19K$7.26168.36K
2024-06-05Newton ToddBuy23.19K$7.26168.36K
2024-06-05BEHRENS M KATHLEENBuy23.19K$7.26168.36K
2024-06-05HAWKINS WILLIAM ABuy23.19K$7.26168.36K
2024-06-05Olson TiffanyBuy28.99K$7.26210.45K
2024-06-05PUHY DOROTHY EBuy28.99K$7.26210.45K
2024-05-08Hulse William Frank IVSell8.90K$7.2064.05K
2024-04-23Hulse William Frank IVSell8.90K$6.5157.91K
2024-04-08Hulse William Frank IVSell8.90K$6.9061.38K
2024-03-13Hulse William Frank IVSell20.38K$7.95162.03K
2024-03-04Hulse William Frank IVSell15.35K$8.26126.80K
2024-03-01PUHY DOROTHY EOther0——
2024-03-01Olson TiffanyOther0——
2024-03-01Hulse William Frank IVBuy59.13K——
2024-03-01Hulse William Frank IVBuy71.54K$8.63617.40K
2024-03-01Whitlow Ricci SBuy58.48K——
2024-03-01Whitlow Ricci SBuy70.75K$8.63610.62K
2024-03-01DOUG RICEBuy70.75K$8.63610.62K
2024-03-01DOUG RICEBuy58.48K——
2024-02-20Whitlow Ricci SSell15.27K$8.01122.35K
2024-02-16Whitlow Ricci SSell15.49K$8.07125.07K
2024-02-15Whitlow Ricci SSell15.20K$8.06122.50K
2024-02-14Whitlow Ricci SSell15.85K$8.03127.27K
2023-12-22Falcon Fund 2 Holding Company, L.P.Buy28.20M$0.0028.20K
2023-12-22Falcon Fund 2 Holding Company, L.P.Sell90.00K$3.85346.50K
2023-11-21DOUG RICEBuy5.00K$7.1635.79K
2023-07-05DOUG RICEBuy97.20K——
2023-07-05DOUG RICEBuy94.00K$6.44605.36K
2023-07-05DOUG RICEOther0——
2023-06-23Capper Joseph HBuy42.02K$6.50273.33K
2023-06-22Capper Joseph HBuy57.98K$6.33367.10K
2023-06-13BIERMAN JAMES LBuy35.35K$4.95175.00K
2023-06-13BEHRENS M KATHLEENBuy35.35K$4.95175.00K
2023-06-13GARDNER PHYLLISBuy35.35K$4.95175.00K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 230, holders -11 vs prior quarter. Ownership 76.55%.

HolderSharesChangeChange %Value
ESSEX WOODLANDS MANAGEMENT, INC.28.20M00.00%108.55M
BLACKROCK, INC.12.15M243.17K+2.04%46.79M
TRIGRAN INVESTMENTS, INC.7.17M-1.34K-0.02%27.62M
STATE STREET CORP5.58M522.12K+10.33%21.48M
VANGUARD CAPITAL MANAGEMENT LLC5.19M21.05K+0.41%19.97M
NANTAHALA CAPITAL MANAGEMENT, LLC4.77M1.37M+40.33%18.36M
PARADIGM CAPITAL MANAGEMENT INC/NY4.07M662.80K+19.44%15.68M
GEODE CAPITAL MANAGEMENT, LLC3.14M262.33K+9.10%12.11M
GOLDMAN SACHS GROUP INC2.67M1.48M+124.84%10.26M
AQR CAPITAL MANAGEMENT LLC2.47M1.55M+170.29%9.50M
RENAISSANCE TECHNOLOGIES LLC2.44M-575.64K-19.06%9.41M
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.2.06M38.37K+1.90%7.92M
DIMENSIONAL FUND ADVISORS LP1.94M-749.15K-27.81%7.49M
CANNELL CAPITAL LLC1.87M373.25K+24.93%7.20M
NORTHERN TRUST CORP1.32M294.47K+28.78%5.07M
VANGUARD PORTFOLIO MANAGEMENT LLC1.29M184.76K+16.71%4.97M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.27M490.73K+63.25%4.88M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.24M-137.25K-9.95%4.78M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.24M1.24MNew4.78M
MEROS INVESTMENT MANAGEMENT, LP1.12M28.90K+2.64%4.32M
MORGAN STANLEY1.04M230.54K+28.37%4.02M
QUBE RESEARCH & TECHNOLOGIES LTD990.23K-661.29K-40.04%3.81M
CITADEL ADVISORS LLC825.84K49.40K+6.36%3.18M
JANE STREET GROUP, LLC792.31K266.84K+50.78%3.05M
VANGUARD FIDUCIARY TRUST CO775.09K-47.88K-5.82%2.98M

Earnings and financials

MiMedx Group, Inc. (MDXG) trades at $3.95, with a market cap of $575.93M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

MiMedx Group (MDXG) Financials: Revenue & Earnings

MDXG$3.95+0.05 +1.31%

$575.93M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History